Early genetic approaches utilizing RNA interference suggested that EGFR depletion from glioma cells could induce a partial cell cycle arrest in G2M [61], while later studies showed that treatment with EGFR specific siRNAs had no inhibitory effect on cell proliferation, migration, and activation status of EGFR-coupled signaling cascades [62]. The gene discussed is EGFR; the disease is central nervous system cancer.